Affiliation:
1. General Medicine Department Xigu Hospital of Lanzhou University Second Hospital Lanzhou China
2. The Second Affiliated Hospital of Fujian Medical University Quanzhou China
3. Tianjin University of Traditional Chinese Medicine Tianjin China
4. Endocrinology Department Lanzhou University Second Hospital Lanzhou China
Abstract
AbstractThe goal of this overview of systematic reviews (SRs) and meta‐analyses (MAs) was to methodically gather, evaluate and summarize the data supporting the use of hyperbaric oxygen therapy (HBOT) to treat diabetic foot ulcers (DFUs). The Cochrane Library, Embase, PubMed, Web of Science and Embase were all searched thoroughly to identify SRs/MAs that qualified. AMSTAR‐2 tool, PRISMA checklists and GRADE system were applied by two reviewers independently to assess the methodological quality, reporting and evidence quality of the included SRs/MAs, respectively. Eleven SRs/MAs were enrolled in this overview. According to AMSTAR‐2, a very low methodological quality assessment was given to the included SRs/MAs due to the limitations of items 2, 4 and 7. For the PRISMA, the overall quality of reporting is not satisfactory due to missing reporting on protocol, search, as well as additional analysis. The majority of outcomes had low‐ to moderate‐quality evidence, and no high‐quality evidence was found to support the role of HBOT for DFUs, according to GRADE. To conclude, the potential of HBOT in treating DFUs is supported by evidence of low to moderate quality. More rigorously designed, high‐level studies are needed in the future to determine the evidence for HBOT for DFU, including the timing, frequency and duration of HBOT interventions.